Squarepoint
ALDX icon

Squarepoint’s Aldeyra Therapeutics ALDX Stock Holding History

Squarepoint’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,193
Closed -$125K – 4004
2024
Q1 		$125K Sell
38,193
-34,771
-48% -$114K ﹤0.01% 3747
2023
Q4 		$256K Buy
+72,964
New +$225K ﹤0.01% 3454
2023
Q2 		– Sell
-67,048
Closed -$666K – 3521
2023
Q1 		$666K Buy
+67,048
New +$474K ﹤0.01% 2141
2022
Q3 		– Sell
-10,964
Closed -$44K – 2946
2022
Q2 		$44K Sell
10,964
-17,328
-61% -$59.6K ﹤0.01% 2718
2022
Q1 		$126K Sell
28,292
-73,187
-72% -$292K ﹤0.01% 2573
2021
Q4 		$406K Buy
101,479
+56,352
+125% +$430K ﹤0.01% 2281
2021
Q3 		$396K Buy
45,127
+26,858
+147% +$246K ﹤0.01% 2090
2021
Q2 		$207K Buy
+18,269
New +$220K ﹤0.01% 2802
2020
Q4 		– Sell
-39,349
Closed -$292K – 2871
2020
Q3 		$292K Sell
39,349
-106,341
-73% -$687K ﹤0.01% 1813
2020
Q2 		$608K Buy
145,690
+115,182
+378% +$421K 0.01% 1196
2020
Q1 		$75K Buy
+30,508
New +$137K ﹤0.01% 1683
2019
Q4 		– Sell
-61,695
Closed -$325K – 2451
2019
Q3 		$325K Sell
61,695
-62,343
-50% -$336K ﹤0.01% 1851
2019
Q2 		$744K Buy
124,038
+48,734
+65% +$367K 0.01% 1439
2019
Q1 		$680K Buy
75,304
+7,099
+10% +$60.3K 0.01% 1322
2018
Q4 		$566K Buy
68,205
+56,505
+483% +$579K 0.01% 1182
2018
Q3 		$161K Buy
+11,700
New +$94.9K ﹤0.01% 1820
2017
Q4 		– Sell
-22,070
Closed -$159K – 2058
2017
Q3 		$159K Buy
+22,070
New +$115K ﹤0.01% 1443

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Squarepoint's ALDX Position: Q2 2024 in Review

Squarepoint sold out of Aldeyra Therapeutics (ALDX) in Q2 2024, closing a stake of 38,193 shares — an estimated $125K sold.

Squarepoint first reported a position in ALDX in Q3 2017 and held it in 17 quarters. The position peaked at $744K in Q2 2019. 103 funds tracked by Wall St. Rank hold ALDX as of Q2 2024.

  • Squarepoint reported no remaining Aldeyra Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 38,193 Aldeyra Therapeutics shares in Q2 2024, an estimated $125K.
  • Squarepoint first reported a position in Aldeyra Therapeutics in Q3 2017 and held it in 17 quarters.
  • Squarepoint's Aldeyra Therapeutics position peaked at $744K in Q2 2019.
  • 103 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.